Merck stock price target lowered to $95 by Bernstein SocGen
Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...
Barchart on MSN2d
Wall Street Predict 92% Upside for This Dividend Stock: Should You Buy It Now?
Merck (MRK) is a leading global healthcare company recognized for its groundbreaking pharmaceutical products and vaccines.
HPV 'cures' are popping up online, but here's the truth about the STI and its vaccine
They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...
The Daily Nonpareil4d
Bill would require parental consent for children’s HPV vaccine
HPV can cause several types of genital cancer, including cervical cancer, penile cancer, anal cancer and vaginal cancer.